Patients With Brain Metastases May Now Have a Better Chance of Inclusion in Clinical Trials
February 2nd 2018Patients whose cancers have metastasized to the brain or central nervous system are often excluded from clinical trials, but now, new guidelines may help researchers identify appropriate clinical trials in which these people may be included.
Brain Training Is Key in Helping Cognitive Function in Breast Cancer Survivors
February 1st 2018Changes in cognitive function, or chemobrain, are common among patients who survive breast cancer. However, limited efforts have been put in to understanding or managing these cognitive changes in survivors. Now, there is a web site that can help with just that.
Promising Agent Shows Significant Activity in Patients with Advanced Systemic Mastocytosis
December 14th 2017Results of a phase I trial presented showed that the agent BLU-285 (Avapritinib) agent was well tolerated among patients with an advanced or aggressive form of systemic mastocytosis (ASM), a rare blood disorder that originates in mast cells.